Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

22 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

RusNano Articles

Nanolek and Lentigen to initiate innovative flu vaccine production in Russia

24 April 2013

Nanolek and Bilthoven Biologicals to start first production of inactivated polio vaccine in Russia

17 January 2013

Illumina to buy Verinata; Rusnano et al invest in Marinus

8 January 2013

Russia's new drugmaker NovaMedica expects production site decision early 2013

15 November 2012

CoDa Therapeutics gets Russian investment boost

30 July 2012

Domain partners with RusNano on drug production in Russia

7 March 2012

RusNano to start production of vaccines and organogels

9 January 2012

Russia’s RusNano invests in Selecta and BIND to develop and commercialize vaccines and cancer drugs

30 October 2011

Russia's RusNano and the UK's Xenetic Biosciences explore joint projects in biotech sector

12 September 2011

Pro Bono Bio, an Anglo/Russian medical nanotech firm, debuts today

12 September 2011

Rusnano and partners set up SynBio innovative pharmaceuticals project in Russia

9 August 2011

Russia’s Rusnano and US Domain Associates to focus on development of innovative drugs

25 July 2011

Russian Rusnano to invest nearly $100 million in development of innovative drugs with HSCI

13 January 2011

Showing 1-13 of 13 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Is failure to adopt business process management putting the pharma industry at risk?
  • New Zealand declines Alexion's funding application for Solaris
  • HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
  • Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
  • Elan makes "transformational" acquisitions and a divestment
  • Is failure to adopt business process management putting the pharma industry at risk?
  • New Zealand declines Alexion's funding application for Solaris
  • HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
  • Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
  • Elan makes "transformational" acquisitions and a divestment

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS